• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Amgen Inc., Thousand Oaks, CA, USA, Vienna, Austria

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 1 of 1

  • Page:
  • 1

Impact of Time Since Diagnosis on Inebilizumab Efficacy: Post-hoc Phase 3 MINT Trial Data Analysis

Author:Ali Habib  James Howard  Michael Benatar  Emma Ciafaloni  M. Isabel Leite  Kimiaki Utsugisawa  John Vissing  Sarah Bray  Michaela Schlader-Ratzinger  Catherine Najem  Blanca Canales  Sue Cheng  Richard Nowak  

Topic:Autoimmune Neurology  

Program Number:P1.053  

Author Institution:University of California, Irvine, Irvine, CA, USA, Orange, CA  University of North Carolina, Chapel Hill, NC, USA, Chapel Hill, NC  University of Miami Miller School of Medicine, Miami, FL, USA, Miami, FL  University of Rochester, Rochester, NY, USA, Rochester, NYHanamaki General Hospital, Hanamaki, Japan, Hanamaki, Japan  University of Copenhagen, Copenhagen, Denmark, Copenhagen, Denmark  Amgen Ltd., Cambridge, United Kingdom  Amgen Inc., Thousand Oaks, CA, USA, Vienna, Austria  Amgen Inc., Thousand Oaks, CA, USA, Horsham, PA  Amgen Inc., Thousand Oaks, CA, USA, Humble, TXYale University School of Medicine, New Haven, CT, USA, New Haven, CT  

  • View Abstract
  • View Disclosure

Displaying 1 - 1 of 1

  • Page:
  • 1

© 2026 Mira Smart Conference | http://www.mirasmart.com